Bio Essence Corporation
BIOE
$0.18
-$0.07-27.96%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 586.28% | 485.68% | 2,071.08% | 7,419.48% | 64.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 586.28% | 485.68% | 2,071.08% | 7,419.48% | 64.70% |
| Cost of Revenue | 497.88% | 338.82% | 162.54% | 26.01% | -61.98% |
| Gross Profit | 626.63% | 557.95% | 255.63% | 663.36% | 82.99% |
| SG&A Expenses | -45.85% | -21.88% | 171.14% | 100.51% | 58.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.83% | 27.35% | 2,543.11% | 339.50% | 81.56% |
| Operating Income | 357.69% | 295.95% | 40.31% | 30.37% | -8.37% |
| Income Before Tax | 179.99% | 157.32% | 87.91% | -214.36% | -227.66% |
| Income Tax Expenses | 1,225.00% | 0.00% | 200.00% | 200.00% | -50.00% |
| Earnings from Continuing Operations | 179.30% | 157.24% | 87.84% | -215.13% | -226.78% |
| Earnings from Discontinued Operations | -- | -- | 100.00% | 100.00% | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 179.30% | 168.47% | 89.12% | -132.59% | -150.13% |
| EBIT | 357.69% | 295.95% | 40.31% | 30.37% | -8.37% |
| EBITDA | 358.05% | 296.44% | 47.81% | 32.63% | -8.87% |
| EPS Basic | 177.42% | 168.41% | 89.58% | -112.35% | -122.56% |
| Normalized Basic EPS | 177.86% | 157.20% | 88.11% | -213.89% | -207.95% |
| EPS Diluted | 231.57% | 236.52% | 89.58% | -112.35% | -122.56% |
| Normalized Diluted EPS | 177.86% | 157.20% | 88.11% | -213.89% | -207.95% |
| Average Basic Shares Outstanding | 4.57% | 0.00% | 2.74% | 2.74% | 5.08% |
| Average Diluted Shares Outstanding | 4.57% | 0.00% | 2.74% | 2.74% | 5.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |